[Long term study of a new antidiabetic agent in 1183 cases].
作者信息
Riveline B
出版信息
Sem Hop Ther. 1974 Feb;50(2):133-9.
PMID:4612707
Abstract
摘要
相似文献
1
[Long term study of a new antidiabetic agent in 1183 cases].[1183例患者使用新型抗糖尿病药物的长期研究]
Sem Hop Ther. 1974 Feb;50(2):133-9.
2
[Study on Gliclazide, an antidiabetic with a double vascular and metabolic polarity].[格列齐特的研究，一种具有双重血管和代谢极性的抗糖尿病药物]
Mars Med. 1972;109(10):655-8.
3
[The real problem in diabetes (trial of gliclazide, an original molecule with metabolic and vascular properties)].
Therapeutique. 1972 Nov;48(9):569-73.
4
[Clinical study with glypentide, new sulfonylurea hypoglycemic agent].
Rev Iber Endocrinol. 1974 Sep-Oct;21(125):427-30, 433-8, 441-2 passim.
5
[Clinical study of a new oral hypoglycemic agent: glypentide (UR-661)].
Rev Iber Endocrinol. 1974 Jul-Aug;21(124):347-62.
6
[Gliclazide, a new antidiabetic with hemobiologic and vascular properties].[格列齐特，一种具有血液生物学和血管特性的新型抗糖尿病药物]
Lyon Med. 1972 Oct 22;228(16):383-5.
7
[A new antidiabetic agent: glyclazide. A study of glycemic regulation].[一种新型抗糖尿病药物：格列齐特。血糖调节研究]
Nouv Presse Med. 1974 Feb 2;3(5):249-51.
8
[Effect of gliclazide on platelet behavior].格列齐特对血小板行为的影响
Nouv Presse Med. 1974 Oct 5;3(33):2099-100.
9
10
[Clinical trial of glypizide].
Rev Iber Endocrinol. 1974 Jan;21(121):61-73.
Zotero 插件